Pharmafile Logo

Peter Impey

- PMLiVE

Novo Nordisk to cuts 9,000 jobs in an effort to streamline its operations

The transition will help the company meet the rising global demand in the obesity market

- PMLiVE

Inizio appoints Ryan Quigley as new CEO

Ryan was previously COO at Inizio and has worked in the industry for 25 years

- PMLiVE

Inizio appoints Ryan Quigley as CEO

Inizio have appointed Ryan Quigley as Chief Executive Officer, effective 9 September 2025. Paul Taaffe will remain closely involved with the company as an Advisor and board member going forward. ...

Inizio

- PMLiVE

Ready, Set, Rebrand

What does the creative process of a rebrand look like from concept to completion? We asked Creative Director, Garrick Middleton and Senior Creative & Digital Designer, Jordan Ikin just that....

LOVELIVE

- PMLiVE

Lilly and Circle Pharma agree to collaborate on new oral macrocycle therapies

The agreement is part of the Lilly Catalyze360 model, designed to empower early-stage biotechs

- PMLiVE

Emma Bush appointed as CNX Therapeutics’ Vice President, Commercial

Bush has previously held roles at Galderma, GSK and Teva

- PMLiVE

Invivyd working with FDA towards potential Biologics License Application for COVID-19

The company plans head-to-head safety evaluation with COVID-19 vaccine, pending regulatory alignment

- PMLiVE

Adam Raff appointed as Orbital Therapeutics’ Senior Vice President, Clinical Development

Raff will lead Clinical and Regulatory Operations and will be part of the company’s executive leadership team

- PMLiVE

Why Trust Remains the Primary Driver of Pharma Success

In an age of precision medicine, AI-driven drug discovery, and blockbuster biologics, it’s tempting to assume clinical trial outcomes alone dictate success in pharma. But the reality is more nuanced:...

EatMoreFruit

- PMLiVE

PhotoPharmics’ new advisory board to guide launch of FDA Breakthrough device for Parkinson’s

The US-based company develops light-based therapies for neurodegenerative conditions

- PMLiVE

TRIMTECH Therapeutics establishes Scientific Advisory Board

Alessio Ciulli has been appointed as Chair of the board

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links